Giancarlo Logroscino Selected Research

Alzheimer Disease (Alzheimer's Disease)

6/2021	A New Presenilin 1 (Psen1) Mutation (p.Cys263Trp) as a Cause of Both Early and Late-Onset Alzheimer's Disease in a Large Italian Family.
1/2021	proNGF Measurement in Cerebrospinal Fluid Samples of a Large Cohort of Living Patients With Alzheimer's Disease by a New Automated Immunoassay.
9/2020	Biomarker Testing: Piercing the Fog of Alzheimer's and Related Dementia.
6/2019	Comparative evaluation of two immunoassays for cerebrospinal fluid β-Amyloid1-42 measurement.
1/2019	Are antibodies directed against amyloid-β (Aβ) oligomers the last call for the Aβ hypothesis of Alzheimer's disease?
1/2019	Comparative Analysis of C9orf72 and Sporadic Disease in a Large Multicenter ALS Population: The Effect of Male Sex on Survival of C9orf72 Positive Patients.
1/2019	Sensorial frailty: age-related hearing loss and the risk of cognitive impairment and dementia in later life.
1/2019	A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease.
12/2018	Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review.
11/2018	BACE inhibitors in clinical development for the treatment of Alzheimer's disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giancarlo Logroscino Research Topics

Disease

31	Alzheimer Disease (Alzheimer's Disease) 06/2021 - 04/2005
22	Cognitive Dysfunction 01/2021 - 05/2009
20	Dementia (Dementias) 11/2021 - 05/2009
19	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 01/2010
11	Parkinson Disease (Parkinson's Disease) 01/2016 - 09/2002
10	Stroke (Strokes) 01/2019 - 03/2009
7	Disease Progression 08/2021 - 03/2011
6	Frailty 01/2021 - 04/2012
6	Language Development Disorders (Semantic-Pragmatic Disorder) 01/2021 - 01/2014
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 12/2012
5	Hypertension (High Blood Pressure) 10/2020 - 04/2013
5	Mental Disorders (Mental Disorder) 01/2019 - 12/2016
4	Hearing Loss (Hearing Impairment) 11/2021 - 01/2014
4	Frontotemporal Dementia (Semantic Dementia) 01/2019 - 01/2016
3	Drug-Related Side Effects and Adverse Reactions 09/2018 - 12/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2017 - 02/2005
3	Muscle Spasticity (Spastic) 01/2015 - 03/2013
3	Amyloid Plaque 10/2014 - 10/2010
3	Meningoencephalitis 03/2014 - 12/2011
3	Coma (Comas) 03/2010 - 11/2005
3	Status Epilepticus (Complex Partial Status Epilepticus) 02/2010 - 11/2005
2	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2022 - 01/2016
2	Motor Neuron Disease (Primary Lateral Sclerosis) 07/2021 - 05/2013
2	Primary Progressive Aphasia 01/2021 - 01/2018
2	Depressive Disorder (Melancholia) 01/2021 - 01/2018
2	Bipolar Disorder (Manic Depressive Psychosis) 09/2018 - 12/2016
2	Movement Disorders (Movement Disorder) 01/2018 - 03/2013
2	Malnutrition (Nutritional Deficiencies) 12/2015 - 02/2011
2	Deglutition Disorders (Dysphagia) 11/2013 - 06/2013
2	Atrophy 06/2013 - 10/2010
2	Ischemic Stroke 04/2012 - 11/2010
2	Edema (Dropsy) 02/2012 - 12/2011
2	Neoplasms (Cancer) 11/2011 - 03/2011
2	Migraine Disorders (Migraine) 08/2009 - 07/2006
1	Thrombocytopenia (Thrombopenia) 05/2022
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2011
14	Amyloid (Amyloid Fibrils)IBA 01/2019 - 10/2010
6	Coffee FDA Link 01/2015 - 09/2002
5	VaccinesIBA 01/2020 - 12/2011
5	Type A Botulinum Toxins (Botox)FDA Link 08/2015 - 03/2013
5	bapineuzumabIBA 10/2014 - 12/2011
4	Biological ProductsIBA 01/2022 - 01/2017
4	Peptides (Polypeptides)IBA 06/2019 - 10/2010
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2010
4	AntibodiesIBA 01/2019 - 02/2012
4	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 09/2018 - 12/2016
4	HomocysteineIBA 01/2018 - 08/2004
4	solanezumabIBA 01/2018 - 03/2014
4	Pharmaceutical PreparationsIBA 12/2017 - 01/2011
4	incobotulinumtoxinA FDA Link 08/2016 - 03/2013
4	ApolipoproteinsIBA 12/2012 - 09/2003
3	CholesterolIBA 10/2020 - 01/2017
3	Antipsychotic Agents (Antipsychotics)IBA 01/2019 - 01/2015
3	tau Proteins (tau Protein)IBA 01/2019 - 02/2012
3	AntioxidantsIBA 12/2018 - 02/2011
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2018 - 05/2011
3	Fatty Acids (Saturated Fatty Acids)IBA 12/2018 - 05/2011
3	gantenerumabIBA 01/2018 - 03/2014
3	Monoclonal AntibodiesIBA 01/2016 - 03/2014
3	AN-1792IBA 03/2014 - 12/2011
3	Apolipoproteins E (ApoE)IBA 02/2012 - 04/2005
2	Retinaldehyde (Retinal)IBA 11/2021 - 08/2015
2	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2021 - 12/2017
2	HDL CholesterolIBA 10/2020 - 01/2017
2	Riluzole FDA LinkGeneric 01/2017 - 09/2013
2	Monounsaturated Fatty AcidsIBA 01/2017 - 05/2011
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2017 - 05/2011
2	hydromethylthionineIBA 01/2016 - 01/2016
2	Trichloroethylene (Trichloroethene)IBA 12/2015 - 12/2008
2	SmokeIBA 12/2015 - 10/2004
2	Caffeine (No Doz)FDA LinkGeneric 01/2015 - 03/2009
2	Antidepressive Agents (Antidepressants)IBA 01/2015 - 10/2011
2	TeaIBA 01/2015 - 03/2009
2	Humanized Monoclonal AntibodiesIBA 10/2014 - 09/2014
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 03/2011 - 10/2010
2	Uric Acid (Urate)IBA 02/2011 - 10/2007
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2011 - 03/2009
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2011 - 04/2006
2	Anticonvulsants (Antiepileptic Drugs)IBA 02/2010 - 11/2005
2	LipidsIBA 08/2009 - 07/2006
2	IronIBA 12/2008 - 06/2006
1	fibrin fragment D (D-dimer)IBA 05/2022
1	Indicators and Reagents (Reagents)IBA 08/2021
1	SphingolipidsIBA 07/2021
1	Presenilin-1IBA 06/2021

Therapy/Procedure

13	Therapeutics 12/2021 - 03/2011
8	Continuous Ambulatory Peritoneal Dialysis (CAPD) 11/2021 - 01/2014
6	Immunotherapy 01/2016 - 12/2011
5	Secondary Prevention 01/2022 - 10/2017
3	Renal Dialysis (Hemodialysis) 10/2019 - 12/2015
3	Institutionalization (Institutionalized Persons) 11/2013 - 01/2012
2	Gastrostomy 08/2021 - 06/2013
2	Noninvasive Ventilation 01/2019 - 12/2017
2	Patient Readmission 09/2018 - 12/2016
2	Tracheostomy 01/2017 - 03/2015
2	Extracorporeal Shockwave Therapy 09/2016 - 01/2014
2	Injections 12/2014 - 03/2013
1	Precision Medicine 01/2022
1	Enteral Nutrition (Feeding, Tube) 08/2021